Adherence to the Canadian Thoracic Society Chronic Obstructive Pulmonary Disease Pharmacotherapy Guidelines in a real-world hospital setting

References

• Canadian Institute for Health Information. Hospital stays in Canada report, 2020. Accessed July 10, 2023.
   Google Scholar
• Hermus GSC, Goldfarb D, Theriault L, Bounajm F. Cost risk analysis for chronic lung disease in Canada. The Conference Board of Canada. 2012.
   Google Scholar
• Bourbeau J, Bhutani M, Hernandez P, et al. Canadian Thoracic Society Clinical Practice Guideline on pharmacotherapy in patients with COPD – 2019 update of evidence. Can J Respir Crit Care Sleep Med. 2019;3(4):210–232. doi:10.1080/24745332.2019.1668652.
   Web of Science ®Google Scholar
• Wedzicha JA, Brill SE, Allinson JP, Donaldson GC. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med. 2013;11(1):181. doi:10.1186/1741-7015-11-181.
   PubMedGoogle Scholar
• Wilkinson TMA, Donaldson GC, Hurst JR, Seemungal TAR, Wedzicha JA. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;169(12):1298–1303. doi:10.1164/rccm.200310-1443OC.
   PubMed Web of Science ®Google Scholar
• Dransfield MT, Kunisaki KM, Strand MJ, et al. Acute exacerbations and lung function loss in smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;195(3):324–330. doi:10.1164/rccm.201605-1014OC.
   PubMed Web of Science ®Google Scholar
• Watz H, Tetzlaff K, Magnussen H, et al. Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial. Respir Res. 2018;19(1):251. doi:10.1186/s12931-018-0944-3.
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa0909883.
   PubMed Web of Science ®Google Scholar
• Soler-Cataluña JJ, Martínez-García MÁ, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931.
   PubMed Web of Science ®Google Scholar
• Ho TW, Tsai YJ, Ruan SY, Huang CT, Lai F, Yu CJ. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study. PLoS One. 2014;9(12):e114866. doi:10.1371/journal.pone.0114866.
   PubMed Web of Science ®Google Scholar
• Canadian Institute for Health Information. All-cause readmission to acute care and return to the emergency department, 2012. Accessed July 10, 2023.
   Google Scholar
• Gage B, Lamb J, Dahri K. Evaluation of in-hospital management of inhaler therapy for chronic obstructive pulmonary disease. Can J Hosp Pharm. 2021;74(2):110–116.
   PubMed Web of Science ®Google Scholar
• Aissa S, Knaz A, Maatoug J, et al. Adherence of North-African pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD). Biomed Res Int. 2020;2020:1031845. doi:10.1155/2020/1031845.
   PubMed Web of Science ®Google Scholar
• Aissa S, Knaz A, Benzarti W, et al. Adherence to GOLD guidelines practices in the management of COPD in Tunisia. Eur Respir J. 2018;52(suppl 62):PA751.
   Google Scholar
• Chan KP, Ko FW, Chan HS, et al. Adherence to a COPD treatment guideline among patients in Hong Kong. Int J Chron Obstruct Pulmon Dis. 2017;12:3371–3379. doi:10.2147/COPD.S147070.
   PubMed Web of Science ®Google Scholar
• Duarte-de-Araújo A, Teixeira P, Hespanhol V, Correia-de-Sousa J. COPD: analysing factors associated with a successful treatment. Pulmonology. 2020;26(2):66–72. doi:10.1016/j.pulmoe.2019.05.012.
   PubMed Web of Science ®Google Scholar
• Khalil V, Hua A, Lam S. Evaluation of adherence to chronic obstructive pulmonary disease prescribing guidelines-a single centre study. Med Res Innov. 2019;3(3):1–5. doi:10.15761/MRI.1000161.
   Google Scholar
• Surani S, Aiyer A, Eikermann S, et al. Adoption and adherence to chronic obstructive pulmonary disease GOLD guidelines in a primary care setting. SAGE Open Med. 2019;7:2050312119842221. doi:10.1177/2050312119842221.
   Web of Science ®Google Scholar
• Palmiotti GA, Lacedonia D, Liotino V, et al. Adherence to GOLD guidelines in real-life COPD management in the Puglia region of Italy. Int J Chron Obstruct Pulmon Dis. 2018;13:2455–2462. doi:10.2147/COPD.S157779.
   PubMed Web of Science ®Google Scholar
• Gershon A, Mecredy G, Croxford R, To T, Stanbrook MB, Aaron SD, Canadian Respiratory Research Network. Outcomes of patients with chronic obstructive pulmonary disease diagnosed with or without pulmonary function testing. CMAJ. 2017;189(14):E530–E538. doi:10.1503/cmaj.151420.
   PubMed Web of Science ®Google Scholar